Quinoline tag helps vancomycin breach gram-negative defenses (C&EN)

  • Thread starter Thread starter Astronuc
  • Start date Start date
Click For Summary
SUMMARY

Researchers at the Shanghai Institute of Materia Medica have developed a modified vancomycin derivative by attaching a quinoline group, enabling it to penetrate gram-negative bacteria. This modification allows vancomycin to target Lipid II, a crucial component of the bacterial cell wall, which was previously inaccessible due to the protective outer membrane of gram-negative pathogens. The modified compounds demonstrated effectiveness against multidrug-resistant strains such as Escherichia coli and Salmonella, as well as gram-positive superbugs like MRSA and vancomycin-resistant enterococci, showcasing a significant advancement in antibiotic efficacy.

PREREQUISITES
  • Understanding of antibiotic mechanisms, specifically vancomycin's action.
  • Knowledge of gram-negative and gram-positive bacterial structures.
  • Familiarity with the concept of Lipid II in bacterial cell wall synthesis.
  • Basic principles of medicinal chemistry and drug modification techniques.
NEXT STEPS
  • Research the role of quinoline derivatives in enhancing antibiotic activity.
  • Explore the mechanisms of resistance in gram-negative bacteria.
  • Study the synthesis and application of modified vancomycin compounds.
  • Investigate alternative strategies for overcoming antibiotic resistance in bacterial infections.
USEFUL FOR

This discussion is beneficial for pharmaceutical researchers, microbiologists, and healthcare professionals focused on antibiotic development and resistance mechanisms.

Astronuc
Staff Emeritus
Science Advisor
Gold Member
Messages
22,493
Reaction score
7,401
https://cen.acs.org/pharmaceuticals...3/web/2025/12?sc=251211_sc_eng_fb_cen_boosted

Vancomycin is a common antibiotic used to treat gram-positive bacterial infections. It targets a key building block of the bacterial cell wall called Lipid II, but it can’t reach this lipid in gram-negative pathogens because their outer membranes block such large molecules. Now, chemists at the Shanghai Institute of Materia Medica, Chinese Academy of Sciences have found that attaching a small quinoline group to vancomycin lets it slip inside the bacteria and reach its target (J. Am. Chem. Soc. 2025, DOI: 10.1021/jacs.5c14268).

While the team originally added the quinoline to boost vancomycin’s activity against resistant gram-positive bacteria, several of the modified molecules unexpectedly killed the multidrug-resistant gram-negatives Escherichia coli and Salmonella. They also worked better against stubborn gram-positive superbugs like methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci.
Clever! Talk about serendipity.
 
Reply
  • Like
Likes   Reactions: Spinnor, pinball1970, phyzguy and 3 others

Similar threads

Medical Drug development pipelines for new antibiotics
  • · Replies 2 ·
Replies
2
Views
4K